Cargando…
ActivinA Induced SMAD1/5 Signaling in an iPSC Derived EC Model of Fibrodysplasia Ossificans Progressiva (FOP) Can Be Rescued by the Drug Candidate Saracatinib
Balanced signal transduction is crucial in tissue patterning, particularly in the vasculature. Heterotopic ossification (HO) is tightly linked to vascularization with increased vessel number in hereditary forms of HO, such as Fibrodysplasia ossificans progressiva (FOP). FOP is caused by mutations in...
Autores principales: | Hildebrandt, Susanne, Kampfrath, Branka, Fischer, Kristin, Hildebrand, Laura, Haupt, Julia, Stachelscheid, Harald, Knaus, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166717/ https://www.ncbi.nlm.nih.gov/pubmed/33410098 http://dx.doi.org/10.1007/s12015-020-10103-9 |
Ejemplares similares
-
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021) -
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018) -
Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
por: Pignolo, Robert J., et al.
Publicado: (2020) -
PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series
por: Almonaei, Khulod, et al.
Publicado: (2022) -
Clinical, evolution and therapeutical considerations upon a case of fibrodysplasia ossificans progressiva (FOP)
por: Rogoveanu, O, et al.
Publicado: (2013)